市场调查报告书
商品编码
1617123
到 2030 年伤口护理设备市场预测:按产品类型、操作模式、技术、应用、最终用户和地区进行的全球分析Negative Pressure Wound Therapy Devices Market Forecasts to 2030 - Global Analysis by Product, Wound Type, Mode of Operation, Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球负压伤口护理设备市场规模为 69.7 亿美元,预计到 2030 年将达到 106.4 亿美元,预测期内复合年增长率为 7.3%。
负压伤口护理(NPWT) 设备是创新的医疗设备,利用调节负压(抽吸)来帮助慢性和复杂伤口的癒合。这种治疗可以减少水肿,增加血流量,并有助于清除伤口中多余的液体,加速组织再生和健康组织的发展。 NPWT 设备通常包括引流管、敷料或伤口敷料以及产生负压的帮浦。这种治疗方法通常用于治疗烧伤、手术伤口、褥疮和糖尿病溃疡。 NPWT 设备在现代创伤护理管理中至关重要,因为它们可以增强氧气输送和组织灌注,降低感染风险并加速癒合。
慢性伤口增加
糖尿病性溃疡、静脉溃疡等慢性伤口的盛行率日益增加,正在推动伤口护理(NPWT) 设备市场的发展。慢性伤口的早期癒合和感染预防需要先进的治疗方案。 NPWT 设备作为一种有效的治疗方法越来越受欢迎,因为它们可以改善血流、促进组织再生并最大限度地减少疤痕。由于全球慢性病的流行,对 NPWT 设备的需求增加,市场正在扩大。
併发症的风险
与伤口护理(NPWT) 设备相关的併发症风险限制了市场成长,因为使用不当可能导致组织损伤、感染和创伤治疗延迟。这些风险可能会限制资源匮乏地区的采用,因为它们需要熟练的医疗专业人员来正确安装和监测。此外,由于潜在的副作用,患者可能会避免使用 NPWT,尤其是在居家医疗中。因此,适当的培训和监督的需要是更广泛的市场扩张的障碍。
技术进步
技术创新透过提高设备性能、便携性和使用便利性对市场产生重大影响。更小、更有效、对患者友善的 NPWT 系统是提高患者依从性和扩大使用范围的技术创新的一个例子。无线监控、即时回馈和可调节设定的进步使这些设备更加有效,并减少了恢復时间和併发症。由于这些发展,对 NPWT 设备的需求不断增加,特别是在医院和居家照护环境中。
使用复杂性
使用负压伤口护理(NPWT) 设备的复杂性限制了其广泛采用。这些设备通常需要医疗保健提供者的专门培训,以确保正确的应用和监控。此外,某些模型很难让患者独立使用,尤其是在居家照护环境中。这种复杂性可能会导致治疗错误、患者依从性降低以及营运成本增加。因此,对专业知识和使用者培训的需求已成为市场成长的障碍。
COVID-19 大流行最初因治疗延迟、手术减少和供应链挑战而扰乱了伤口护理(NPWT) 设备市场。医院将资源转移到 COVID-19 护理上,限制了对创伤护理的关注。然而,随着医疗保健系统的復苏,人们对有效伤口管理(尤其是慢性伤口和手术伤口)的认识不断提高,正在重振对 NPWT 设备的需求,并加速疫情后的市场成长。
预计组织再生领域在预测期内将是最大的。
NPWT 刺激组织生长、改善血液循环并促进细胞再生,使其在治疗复杂的慢性伤口方面非常有效。随着人们越来越重视改善患者復原结果和减少併发症,对 NPWT 装置的需求不断增长。这种组织再生的治疗效果促进了 NPWT 设备的广泛使用,也是已开发市场和新兴市场市场发展的驱动力。
预计慢性伤口在预测期内的复合年增长率最高
由于糖尿病、静脉溃疡和压疮等疾病增加了慢性伤口的发生率并需要先进的治疗解决方案,预计慢性伤口领域在预测期内将出现最高的复合年增长率。 NPWT 设备已成为处理这些伤口的首选,因为它们有助于加速癒合、减少感染并改善患者的治疗效果。随着全球慢性伤口负担的增加,对 NPWT 设备的需求预计将增长,从而推动市场扩张。
由于糖尿病、手术部位感染和持续性伤口的增加,预计北美在预测期内将占据最大的市场占有率。由于人口老化和改进创伤护理产品的使用增加,市场正在扩大。完善的医疗基础设施、不断上升的医疗成本以及对使用微创疗法改善患者治疗效果的关注,进一步推动了北美(尤其是美国和加拿大)对 NPWT 设备的需求。
由于人口老化、慢性伤口、糖尿病和手术损伤的日益加剧,预计亚太地区在预测期内的复合年增长率最高。这些设备因其在加速创伤治疗和降低感染风险方面的功效而越来越受欢迎。此外,中国、印度和日本等国家医疗保健基础设施的改善和医疗技术的进步正在推动需求并促进该地区市场的快速成长。
According to Stratistics MRC, the Global Negative Pressure Wound Therapy Devices Market is accounted for $6.97 billion in 2024 and is expected to reach $10.64 billion by 2030 growing at a CAGR of 7.3% during the forecast period. Negative Pressure Wound Therapy (NPWT) Devices are innovative medical devices that use regulated negative pressure (suction) to aid healing in chronic or complex wounds. This treatment speeds up tissue regeneration and the development of healthy tissue by reducing edema, increasing blood flow, and assisting in the removal of extra fluid from the wound. NPWT devices usually include a drainage tube, a dressing or wound cover, and a pump that creates the negative pressure. The treatment is frequently used to treat burn injuries, surgical wounds, pressure sores, and diabetic ulcers. NPWT devices are essential to contemporary wound care management because they enhance oxygenation and tissue perfusion, which lowers the risk of infection and speeds up healing.
Rising Prevalence of Chronic Wounds
The increasing prevalence of chronic wounds, including as diabetic ulcers, pressure ulcers, and venous ulcers, is driving the Negative Pressure Wound Therapy (NPWT) Devices Market. Advanced treatment options are necessary for chronic wounds in order to promote faster healing and prevent infections. NPWT devices are becoming more and more popular as efficient remedies because they improve blood flow, encourage tissue regeneration, and minimize wound size. The market is growing as a result of the increased demand for NPWT devices brought on by the growth in the prevalence of chronic illnesses worldwide.
Risk of Complications
The risk of complications associated with Negative Pressure Wound Therapy (NPWT) devices limits market growth, as improper use can lead to tissue damage, infection, or delayed wound healing. These risks require skilled healthcare professionals for correct application and monitoring, which can restrict adoption in low-resource settings. The potential for adverse effects may also discourage patients from using NPWT, particularly in home care. As a result, the need for proper training and supervision hinders broader market expansion.
Technological Advancements
Technological innovations significantly impact the market by improving device performance, portability, and convenience of use. Smaller, more effective and patient-friendly NPWT systems are examples of innovations that increase patient compliance and broaden use. These gadgets are now more effective, lowering recovery durations and complications because to advancements in wireless monitoring, real-time feedback, and adjustable settings. The need for NPWT devices is growing as a result of these developments, especially in hospitals and home care settings.
Complexity in Usage
The complexity in usage of Negative Pressure Wound Therapy (NPWT) devices limits their widespread adoption. These devices often require specialized training for healthcare providers to ensure proper application and monitoring. Additionally, some models are difficult for patients to use independently, particularly in home care settings. This complexity can lead to errors in treatment, reduced patient compliance, and higher operational costs. As a result, the need for expertise and user training acts as a barrier to market growth.
The COVID-19 pandemic initially disrupted the Negative Pressure Wound Therapy (NPWT) Devices Market through delayed treatments, reduced surgeries, and supply chain challenges. Hospitals redirected resources towards COVID-19 care, limiting the focus on wound care. However, as healthcare systems recover, the demand for NPWT devices is rebounding, driven by increased awareness of effective wound management, especially for chronic and surgical wounds, thereby accelerating market growth post-pandemic.
The tissue regeneration segment is expected to be the largest during the forecast period
The tissue regeneration segment is expected to be the largest during the forecast period as NPWT stimulates tissue growth, improves blood circulation, and accelerates cellular regeneration, making it highly effective for treating complex and chronic wounds. As more focus is placed on improving patient recovery outcomes and reducing complications, the demand for NPWT devices grows. This therapeutic effect of tissue regeneration contributes to the widespread adoption of NPWT devices, fueling market growth in both developed and emerging healthcare markets.
The chronic wounds segment is expected to have the highest CAGR during the forecast period
The chronic wounds segment is expected to have the highest CAGR during the forecast period because conditions such as diabetes, venous ulcers, and pressure sores contribute to a higher incidence of chronic wounds, requiring advanced treatment solutions. NPWT devices help promote faster healing, reduce infection, and improve patient outcomes, making them a preferred choice for managing these wounds. As the global burden of chronic wounds increases, the demand for NPWT devices is expected to grow, boosting market expansion.
North America is anticipated to hold the largest market share during the forecast period due to increasing rates of diabetes, surgical site infections, and persistent wounds. The market is expanding due to the aging population and the growing use of improved wound care products. Further driving up demand for NPWT devices in North America, especially in the U.S. and Canada, are established healthcare infrastructures, increased healthcare spending, and a focus on enhancing patient outcomes using minimally invasive therapies.
Asia Pacific is anticipated to witness the highest CAGR over the forecast period owing to growing aging population, and rising incidences of chronic wounds, diabetes, and surgical injuries. These devices, which aid in faster wound healing and reduce infection risks, are gaining popularity due to their effectiveness. Additionally, improved healthcare infrastructure and advancements in medical technology in countries like China, India, and Japan are boosting demand, contributing to rapid market growth in the region.
Key players in the market
Some of the key players in Negative Pressure Wound Therapy Devices Market include 3M, 4L Health Co. Ltd., Alleva Medical, Cardinal Health, Carilex Medical, ConvaTec Group Plc, Cork Medical, LLC, DeRoyal Industries Inc., Genadyne, Haromed, Lohmann & Rauscher GmbH & Co. KG, Medela AG, Molnlycke Healthcare AB, Paul Hartmann AG, Pensar Medical, LLC, Smith+Nephew, Talley Group Ltd and Triage Meditech Pvt. Ltd.
In October 2024, Convatec collaborated with AbbVie for VYALEV therapy for the treatment of advanced Parkinson's disease in the United States.
In October 2024, Smith+Nephew announced that it has signed a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology - the only ultrasound device currently on the market to deliver 3D preoperative planning.
In July 2024, Smith+Nephew announced an exclusive digital and advanced analytics collaboration with Healthcare Outcomes Performance Company to focus on enhancing solutions for ASC customers, physicians, and their patients through HOPCo's digital health and analytics platforms, myrecovery and Vitals.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.